LXRX Competitors
Lexicon Pharmaceuticals, Inc.
$1.45
+$0.03(+2.11%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
2.21M
52W Range
$1.10 - $2.68
Target Price
--
LXRX competitors: BTX, REGN, RARE, AERI, ESPR. Lexicon Pharmaceuticals, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
LXRX Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals, Inc. | $807.67 | $84.33B | $47.93 | 0.46% | 75 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LXRX | $1.45 | +2.1% | 2.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Lexicon Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW